Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

ClinicalTrials.gov ID: NCT05636618

Public ClinicalTrials.gov record NCT05636618. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 8, 2026, 10:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors

Study identification

NCT ID: NCT05636618
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Perspective Therapeutics; Industry
Enrollment: 300 participants

Conditions and interventions

Conditions

Interventions

[203Pb]VMT-α-NET Drug
[212Pb]VMT-α-NET Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 90 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 26, 2023
Primary completion: Nov 25, 2029
Completion: Dec 25, 2029
Last update posted: Apr 30, 2026

2023 – 2029

United States locations

U.S. sites: 19
U.S. states: 15
U.S. cities: 19

Facility	City	State	ZIP	Site status
Mayo Clinic	Jacksonville	Florida	32224	Recruiting
Biogenix Molecular	Miami	Florida	33165	Recruiting
The University of Chicago	Chicago	Illinois	60637	Recruiting
University of Iowa	Iowa City	Iowa	52242	Recruiting
University of Kentucky	Lexington	Kentucky	40536	Recruiting
Johns Hopkins	Baltimore	Maryland	21287	Recruiting
Barbara Ann Karmanos Cancer Institute	Detroit	Michigan	48201	Recruiting
BAMF Health	Grand Rapids	Michigan	49503	Recruiting
Michigan Health Professionals	Troy	Michigan	48098	Recruiting
Mayo Clinic	Rochester	Minnesota	55905	Recruiting
Washington University	St Louis	Missouri	63110	Recruiting
Nebraska Cancer Specialists	Omaha	Nebraska	68130	Recruiting
University of North Carolina	Chapel Hill	North Carolina	27599	Recruiting
UH Cleveland Medical Center	Cleveland	Ohio	44106	Recruiting
Ohio State University	Columbus	Ohio	43210	Recruiting
Vanderbilt-Ingram Cancer Center	Nashville	Tennessee	37232	Recruiting
Virginia Cancer Specialists	Fairfax	Virginia	22031	Recruiting
Fred Hutchinson Cancer Center	Seattle	Washington	98109	Recruiting
Froedtert Medical College of Wisconsin	Milwaukee	Wisconsin	53226	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05636618, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 30, 2026 · Synced May 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05636618 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →